ResMed , a developer, manufacturer and distributor of medical equipment, has launched its new AirSense10 positive-airway pressure (PAP) device platform, to deliver superior patient comfort and cost-saving efficiency for healthcare providers.
The AirSense 10 series devices work with the company’s AirView patient monitoring software as the cornerstone of its Air Solutions connected care platform, an ecosystem of hardware and software solutions that can streamline the patient compliance monitoring and management process, as well as enhance overall patient outcomes and engagement.
AirView will work with AirSense 10 devices to analyse and report a patient’s usage and compliance, as well as make the device’s status visible to healthcare providers.
ResMed CEO Mick Farrell said: "Our home medical equipment provider customers are faced with the challenge of balancing superior care with the realities of today’s reimbursement environment.
"Extracting new efficiencies from their workflow is critical to keeping their businesses healthy and growing.
"Our new AirSense 10 series PAP therapy devices leverage patient data and communications capabilities to help our customers streamline operations while providing their patients with a supremely comfortable therapy experience."
The AirSense 10 series platform includes four new devices, namely AirSense 10 CPAP, AirSense 10 Elite, AirSense 10 AutoSet and AirSense 10 AutoSet for Her. The devices are currently available in the US and Australia.
AirSense 10 CPAP includes advanced features that are standard with AirSense 10 series devices, while AirSense 10 Elite includes detection of central sleep apneas and Cheyne-Stokes respiration.
The devices featured for sleep-disordered breathing include connected care, remote device settings changes and troubleshooting, integrated HumidAir heated humidification, autoramp and elegant user-friendly controls for patient confidence.